Clinical Trials Search Results

Results 1-10 of 37 for your search
Show Search Criteria
Palliative Radiation Therapy in Treating Patients with Metastatic Solid Tumors with Highest Risk for Bone Metastases
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 7 locations
Pembrolizumab and Radiation Therapy for the Treatment of Metastatic Merkel Cell Carcinoma
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: Stanford Cancer Institute Palo Alto, Palo Alto, California
Durvalumab and Tremelimumab in Treating Patients with Somatically Hypermutated Recurrent or Refractory Solid Tumors
Status: Approved
Age: 18 years and over
Gender: Male or Female
Location: University of Kentucky / Markey Cancer Center, Lexington, Kentucky
Palliative Radiation Therapy, Aldesleukin, and Nivolumab with or without Ipilimumab in Treating Patients with Refractory Metastatic Melanoma
Status: Approved
Age: 18 to 80 years
Gender: Male or Female
Location: University of Minnesota / Masonic Cancer Center, Minneapolis, Minnesota
Palliative Care with Dignity Therapy in Supporting Elderly Patients with Cancer
Status: Active
Age: 55 years and over
Gender: Male or Female
Location: 6 locations
1 2 3 4 Next >